Please wait a minute...
 Home  About the Journal Editorial Board Aims & Scope Peer Review Policy Subscription Contact us
 
Early Edition  //  Current Issue  //  Open Special Issues  //  Archives  //  Most Read  //  Most Downloaded  //  Most Cited
Aging and Disease    2014, Vol. 5 Issue (5) : 327-339     DOI: 10.14336/AD.2014.0500327
|
Catecholamines, Steroids and Immune Alterations in Ischemic Stroke and Other Acute Diseases
Juliane Schulze, Antje Vogelgesang, Alexander Dressel
Section of Neuroimmunology, Department of Neurology, University Medicine Greifswald, Germany
Download: PDF(0 KB)   HTML
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks    
Abstract  

The outcome of stroke patients is not only determined by the extent and localization of the ischemic lesion, but also by stroke-associated infections. Stroke-induced immune alterations, which are related to stroke-associated infections, have been described over the last decade. Here we review the evidence that catecholamines and steroids induced by stroke result in stroke-induced immune alterations. In addition, we compare the immune alterations observed in other acute diseases such as myocardial infarction, brain trauma, and surgical trauma with the changes seen in stroke-induced immune alterations.

Keywords ischemic stroke      immune      aging      catecholamines      steroids     
Corresponding Authors: Alexander Dressel   
Issue Date: 12 November 2014
Service
E-mail this article
E-mail Alert
RSS
Articles by authors
Juliane Schulze
Antje Vogelgesang
Alexander Dressel
Cite this article:   
Juliane Schulze,Antje Vogelgesang,Alexander Dressel. Catecholamines, Steroids and Immune Alterations in Ischemic Stroke and Other Acute Diseases[J]. Aging and Disease, 2014, 5(5): 327-339.
URL:  
http://www.aginganddisease.org/EN/10.14336/AD.2014.0500327     OR     http://www.aginganddisease.org/EN/Y2014/V5/I5/327
Most innate immune cellsBoth αAR and βAR families
Bone marrow-derived dendritic cellsα1AR α2AR
β1AR β2AR
Monocytes/macrophagesβ2AR
α1AR α2AR
Natural killer cellsβ2AR
Resting and activated B cells
Naïve T cells and Th1 cells, but not Th2 cells
Regulatory T cells and Th17 cellsNo data available
Table 1.  Expression of adrenoreceptors on immune cells.
GlucorticoidsCatecholamines
DC

induce apoptosis in immature DCs [29]

reduction of MHCII, costimulatory molecules and cytokine expression [30, 31]

inhibition of migration in vivo and in vitro [32]; [33] by downregulation of CCR7 [34]

induction of a tolerogenic DC phenotype that induces T cell anergy, suppression of T cells and generates Tregs [35]

enhanced surface expression of MHCII, CD80 and CD86 [36]

control cell migration via α1bAR [37] and induction of an anti-inflammatory cytokine profile [38]

enhancement of IL-33 production thus promoting Th2 responses [39] inhibited the lipopolysaccharide (LPS)-stimulated production of interleukin (IL)-23, IL-12 p40, tumor necrosis factor (TNF)-alpha and IL-6 [40]

Macrophages/monocytes

suppressed activation by IL-10 induction and inhibition of upregulation of pro-inflammatory CD163 [41]

development of myeloid suppressor cell like phenotype [42]

cAMP/PKA dependent stimulation of IL-10 promoter/enhancer [43]

upregulate L-selectin in vitro [44]

inhibit IL-6 secretion via αAR [45] but

induce secretion of IL-6 (in the presence of GC) via βAR [46]

Neutrophils

suppression of adhesion molecule expression inhibits rolling, adhesion and transmigration [47]

increase of BM-derived neutrophils in blood [48]

promotes necrosis [49]

increase the total circulating neutrophil pool for a few hours [50]

increase expression and release of Hsp72 [51]

suppression of CD11b and inhibition of suppression of CD62L (L-selectin) [52]

decreased phagocytosis of zymosan in vitro [53]

B cells

reduction of splenic and LN B cell numbers

inhibit B cell progenitor proliferation

enhance IgE, suppressed IgG production [54, 55]

state of B cell activation decisive about effect of CA:

- enhanced IgG1 production and IgE on NE exposure during antigen processing or after Th2 coculture [56]

- increase in costimulatory capacity (CD86 upregulation) [57]

- β2AR engagement in presence of IL-4 enhances IgE [58]

T cells

affect thymocyte maturation by inducing apoptosis in thymocytes; more sensitive than Teff than Treg cells [59, 60]

physiological doses: shift from Th1 response to Th2 [61]

pharmacological doses induce anti-inflammation:

- reduce RORγt in Th17 cells [62]

- inhibit TH1 function by direct inhibition of STAT4 and T-bet [63, 64]

- suppress STAT6 function in Th2 by interfering with GATA [65, 66]

β2AR engagement enhances IFNγ production in TH1 cells the presence of IL-12 in pre activated TH1 cells [67]

inhibit IFN-γ in resting TH1 cells [13]

NK cells

impair NK cell function via histone deacetylation and transrepression [68]

inhibit NK cytotoxic functions by:

- reduced TNF-α, IFN-γ, and GM-CSF

- impaired, target binding [69]

Table 2.  Cellular effects of stress hormones in immune cells
Figure 1.  Systemic effects of the stress response in ischemic stroke. The scheme depicts those organ specific immune alterations that occur in stroke and have been experimentally linked to the activation of either the HPA axis or the sympathetic nervous system. As a result the stress response reduces the ability to fight bacteria and increases the risk of subsequent infection. (HPA, hypothalamic-pituitary gland-adrenal; iNKT, invariant natural killer T cells; IFN-g, Interferon-gamma; IL-10, Interleukin-10; TNF-a, tumor necrosis factor-alpha; ↑, increase, ↓, decrease)
Ischemic stroke (IS)Traumatic brain injury (TBI)Myocardial infarction (MI)(Surgical) trauma (ST/T)
animalhumananimalhumananimalhumananimalhuman
innate immune system
White blood cell[98, 100][101][102][98, 103]
monocytic HLA-DR[98, 100, 104][98][105, 106][106, 107]
monocytic LPS activatability[98, 104][98][108]
cytokines
IL-10[104, 109][110][94][43][111]
TNF-α[77][100][110][98][112]
IL-6[98, 109][110][101, 113][98, 102][112][111]
HMGB-1[76, 99][114][99][95, 115]
adaptive immune system
circulatory lymphocyte number[77][7, 100, 109, 116, 117][113][98][105, 106][107]
T lymphocyte activation[116][76][118]
IgG, IgM[117][119, 120]
T-cell proliferation to mitogen[117] [76][113]
hormones
catecholamines[77][4, 75, 76, 109][94][96, 97][95]
cortisol/corticosterone[77][100, 104][98][106]
Table 3.  Immune alterations immediately after disease onset.
[1] Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ(2006). Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet, 367:1747-1757
http://dx.doi.org/10.1016/S0140-6736(06)68770-9
[2] Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G(2010). Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation, 121:948-954
http://dx.doi.org/10.1161/CIRCULATIONAHA.109.192666
[3] Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C(2012). Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 380:2197-2223
http://dx.doi.org/10.1016/S0140-6736(12)61689-4
[4] Harms H, Reimnitz P, Bohner G, Werich T, Klingebiel R, Meisel C(2011). Influence of stroke localization on autonomic activation, immunodepression, and post-stroke infection. Cerebrovasc Dis, 32:552-560
http://dx.doi.org/10.1159/000331922
[5] Vermeij FH, Scholte op Reimer WJ, de Man P, van Oostenbrugge RJ, Franke CL, de Jong G(2009). Stroke-associated infection is an independent risk factor for poor outcome after acute ischemic stroke: data from the Netherlands Stroke Survey. Cerebrovasc Dis, 27:465-471
http://dx.doi.org/10.1159/000210093
[6] Dirnagl U, Klehmet J, Braun JS, Harms H, Meisel C, Ziemssen T(2007). Stroke-induced immunodepression: experimental evidence and clinical relevance. Stroke, 38:770-773
http://dx.doi.org/10.1161/01.STR.0000251441.89665.bc
[7] Vogelgesang A, Grunwald U, Langner S, Jack R, Broker BM, Kessler C(2008). Analysis of lymphocyte subsets in patients with stroke and their influence on infection after stroke. Stroke, 39:237-241
http://dx.doi.org/10.1161/STROKEAHA.107.493635
[8] Urra X, Obach V, Chamorro A(2009). Stroke induced immunodepression syndrome: from bench to bedside. Curr Mol Med, 9:195-202
http://dx.doi.org/10.2174/156652409787581574
[9] Meisel C, Schwab JM, Prass K, Meisel A, Dirnagl U(2005). Central nervous system injury-induced immune deficiency syndrome. Nat Rev Neurosci, 6:775-786
[10] Straub RH, Westermann J, Scholmerich J, Falk W(1998). Dialogue between the CNS and the immune system in lymphoid organs. Immunol Today, 19:409-413
http://dx.doi.org/10.1016/S0167-5699(98)01297-3
[11] Kohm AP, Sanders VM(1999). Suppression of antigen-specific Th2 cell-dependent IgM and IgG1 production following norepinephrine depletion in vivo. J Immunol, 162:5299-5308
[12] Sanders VM, Baker RA, Ramer-Quinn DS, Kasprowicz DJ, Fuchs BA, Street NE(1997). Differential expression of the beta2-adrenergic receptor by Th1 and Th2 clones: implications for cytokine production and B cell help. J Immunol, 158:4200-4210
[13] Ramer-Quinn DS, Baker RA, Sanders VM(1997). Activated T helper 1 and T helper 2 cells differentially express the beta-2-adrenergic receptor: a mechanism for selective modulation of T helper 1 cell cytokine production. J Immunol, 159:4857-4867
[14] McQueen Charlene A Comprehensive ToxicologyKidlingtonElsevier Science & Technology2010
[15] Dunn AJ(1995). Interactions Between the Nervous System and the Immune System: Implications for Psychopharmacology. Bloom FE, Kupfer DJ Psychopharmacology: The Fourth Generation of ProgressLippincottWilliams and Wilkins
[16] Musso NR, Brenci S, Setti M, Indiveri F, Lotti G(1996). Catecholamine content and in vitro catecholamine synthesis in peripheral human lymphocytes. J Clin Endocrinol Metab, 81:3553-3557
[17] Josefsson E, Bergquist J, Ekman R, Tarkowski A(1996). Catecholamines are synthesized by mouse lymphocytes and regulate function of these cells by induction of apoptosis. Immunology, 88:140-146
http://dx.doi.org/10.1046/j.1365-2567.1996.d01-653.x
[18] Bergquist J, Tarkowski A, Ekman R, Ewing A(1994). Discovery of endogenous catecholamines in lymphocytes and evidence for catecholamine regulation of lymphocyte function via an autocrine loop. Proc Natl Acad Sci U S A, 91:12912-12916
http://dx.doi.org/10.1073/pnas.91.26.12912
[19] Flierl MA, Rittirsch D, Huber-Lang M, Sarma JV, Ward PA(2008). Catecholamines-crafty weapons in the inflammatory arsenal of immune/inflammatory cells or opening pandora’s box?. Mol Med, 14:195-204
[20] Benschop RJ, Rodriguez-Feuerhahn M, Schedlowski M(1996). Catecholamine-induced leukocytosis: early observations, current research, and future directions. Brain, behavior, and immunity, 10:77-91
http://dx.doi.org/10.1006/brbi.1996.0009
[21] Sanders VM(2012). The beta2-adrenergic receptor on T and B lymphocytes: do we understand it yet?. Brain, behavior, and immunity, 26:195-200
http://dx.doi.org/10.1016/j.bbi.2011.08.001
[22] Kin NW, Sanders VM(2006). It takes nerve to tell T and B cells what to do. Journal of leukocyte biology, 79:1093-1104
http://dx.doi.org/10.1189/jlb.1105625
[23] Straub RH(2004). Complexity of the bi-directional neuroimmune junction in the spleen. Trends Pharmacol Sci, 25:640-646
http://118.145.16.217/magsci/article/article?id=14728247
[24] Pratt WB, Toft DO(2003). Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery. Exp Biol Med (Maywood)228:111-133
[25] Zhou J, Cidlowski JA(2005). The human glucocorticoid receptor: one gene, multiple proteins and diverse responses. Steroids, 70:407-417
http://dx.doi.org/10.1016/j.steroids.2005.02.006
[26] Lowenberg M, Stahn C, Hommes DW, Buttgereit F(2008). Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands. Steroids, 73:1025-1029
http://dx.doi.org/10.1016/j.steroids.2007.12.002
[27] De Bosscher K, Haegeman G(2009). Minireview: latest perspectives on antiinflammatory actions of glucocorticoids. Mol Endocrinol, 23:281-291
http://dx.doi.org/10.1210/me.2008-0283
[28] Baschant U, Tuckermann J(2010). The role of the glucocorticoid receptor in inflammation and immunity. J Steroid Biochem Mol Biol, 120:69-75
http://dx.doi.org/10.1016/j.jsbmb.2010.03.058
[29] Moser M, De Smedt T, Sornasse T, Tielemans F, Chentoufi AA, Muraille E(1995). Glucocorticoids down-regulate dendritic cell function in vitro and in vivo. European journal of immunology, 25:2818-2824
http://dx.doi.org/10.1002/eji.1830251016
[30] Kitajima T, Ariizumi K, Bergstresser PR, Takashima A(1996). A novel mechanism of glucocorticoid-induced immune suppression: the inhibiton of T cell-mediated terminal maturation of a murine dendritic cell line. The Journal of clinical investigation, 98:142-147
http://dx.doi.org/10.1172/JCI118759
[31] Matyszak MK, Citterio S, Rescigno M, Ricciardi-Castagnoli P(2000). Differential effects of corticosteroids during different stages of dendritic cell maturation. European journal of immunology, 30:1233-1242
http://dx.doi.org/10.1002/(SICI)1521-4141(200004)30:4<1233::AID-IMMU1233>3.0.CO;2-F
[32] Tuckermann JP, Kleiman A, Moriggl R, Spanbroek R, Neumann A, Illing A(2007). Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy. The Journal of clinical investigation, 117:1381-1390
http://dx.doi.org/10.1172/JCI28034
[33] Cumberbatch M, Dearman RJ, Kimber I(1999). Inhibition by dexamethasone of Langerhans cell migration: influence of epidermal cytokine signals. Immunopharmacology, 41:235-243
http://dx.doi.org/10.1016/S0162-3109(99)00037-5
[34] Vizzardelli C, Pavelka N, Luchini A, Zanoni I, Bendickson L, Pelizzola M(2006). Effects of dexamethazone on LPS-induced activationand migration of mouse dendritic cells revealed by a genome-wide transcriptional analysis. European journal of immunology, 36:1504-1515
http://dx.doi.org/10.1002/eji.200535488
[35] Rutella S, Danese S, Leone G(2006). Tolerogenic dendritic cells: cytokine modulation comes of age. Blood, 108:1435-1440
http://dx.doi.org/10.1182/blood-2006-03-006403
[36] Kim BJ, Jones HP(2010). Epinephrine-primed murine bone marrow-derived dendritic cells facilitate production of IL-17A and IL-4 but not IFN-gamma by CD4+ T cells. Brain, behavior, and immunity, 24:1126-1136
http://118.145.16.217/magsci/article/article?id=14927807
[37] Maestroni GJ(2000). Dendritic cell migration controlled by alpha 1b-adrenergic receptors. J Immunol, 165:6743-6747
http://dx.doi.org/10.4049/jimmunol.165.12.6743
[38] Maestroni GJ(2002). Short exposure of maturing, bone marrow-derived dendritic cells to norepinephrine: impact on kinetics of cytokine production and Th development. Journal of neuroimmunology, 129:106-114
http://dx.doi.org/10.1016/S0165-5728(02)00188-1
[39] Yanagawa Y, Matsumoto M, Togashi H(2011). Adrenoceptor-mediated enhancement of interleukin-33 production by dendritic cells. Brain, behavior, and immunity, 25:1427-1433
http://dx.doi.org/10.1016/j.bbi.2011.04.012
[40] Goyarts E, Matsui M, Mammone T, Bender AM, Wagner JA, Maes D(2008). Norepinephrine modulates human dendritic cell activation by altering cytokine release. Experimental dermatology, 17:188-196
http://dx.doi.org/10.1111/j.1600-0625.2007.00677.x
[41] Ehrchen J, Steinmuller L, Barczyk K, Tenbrock K, Nacken W, Eisenacher M(2007). Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes. Blood, 109:1265-1274
[42] Varga G, Ehrchen J, Tsianakas A, Tenbrock K, Rattenholl A, Seeliger S(2008). Glucocorticoids induce an activated, anti-inflammatory monocyte subset in mice that resembles myeloid-derived suppressor cells. Journal of leukocyte biology, 84:644-650
http://dx.doi.org/10.1189/jlb.1107768
[43] Platzer C, Docke W, Volk H, Prosch S(2000). Catecholamines trigger IL-10 release in acute systemic stress reaction by direct stimulation of its promoter/enhancer activity in monocytic cells. Journal of neuroimmunology, 105:31-38
http://dx.doi.org/10.1016/S0165-5728(00)00205-8
[44] Rainer TH, Lam N, Cocks RA(1999). Adrenaline upregulates monocyte L-selectin in vitro. Resuscitation, 43:47-55
http://dx.doi.org/10.1016/S0300-9572(99)00121-5
[45] Straub RH, Herrmann M, Berkmiller G, Frauenholz T, Lang B, Scholmerich J(1997). Neuronal regulation of interleukin 6 secretion in murine spleen: adrenergic and opioidergic control. Journal of neurochemistry, 68:1633-1639
[46] Straub RH, Dorner M, Riedel J, Kubitza M, Van Rooijen N, Lang B(1998). Tonic neurogenic inhibition of interleukin-6 secretion from murine spleen caused by opioidergic transmission. The American journal of physiology, 274:R997-1003
[47] Pitzalis C, Pipitone N, Perretti M(2002). Regulation of leukocyte-endothelial interactions by glucocorticoids. Annals of the New York Academy of Sciences, 966:108-118
http://dx.doi.org/10.1111/j.1749-6632.2002.tb04208.x
[48] Stroncek DF, Yau YY, Oblitas J, Leitman SF(2001). Administration of G--CSF plus dexamethasone produces greater granulocyte concentrate yields while causing no more donor toxicity than G--CSF alone. Transfusion, 41:1037-1044
http://dx.doi.org/10.1046/j.1537-2995.2001.41081037.x
[49] Heasman SJ, Giles KM, Ward C, Rossi AG, Haslett C, Dransfield I(2003). Glucocorticoid-mediated regulation of granulocyte apoptosis and macrophage phagocytosis of apoptotic cells: implications for the resolution of inflammation. The Journal of endocrinology, 178:29-36
http://dx.doi.org/10.1677/joe.0.1780029
[50] Parks KR, Davis JM(2012). Epinephrine, cortisol, endotoxin, nutrition, and the neutrophil. Surgical infections, 13:300-306
http://dx.doi.org/10.1089/sur.2012.161
[51] Giraldo E, Multhoff G, Ortega E(2010). Noradrenaline increases the expression and release of Hsp72 by human neutrophils. Brain, behavior, and immunity, 24:672-677
http://118.145.16.217/magsci/article/article?id=14927655
[52] Trabold B, Gruber M, Frohlich D(2007). Functional and phenotypic changes in polymorphonuclear neutrophils induced by catecholamines. Scandinavian cardiovascular journal : SCJ, 41:59-64
http://dx.doi.org/10.1080/14017430601085948
[53] Kaufmann I, Eisner C, Richter P, Huge V, Beyer A, Chouker A(2007). Psychoneuroendocrine stress response may impair neutrophil function in complex regional pain syndrome. Clin Immunol, 125:103-111
http://dx.doi.org/10.1016/j.clim.2007.07.004
[54] Cupps TR, Edgar LC, Thomas CA, Fauci AS(1984). Multiple mechanisms of B cell immunoregulation in man after administration of in vivo corticosteroids. J Immunol, 132:170-175
[55] Cupps TR, Gerrard TL, Falkoff RJ, Whalen G, Fauci AS(1985). Effects of in vitro corticosteroids on B cell activation, proliferation, and differentiation. The Journal of clinical investigation, 75:754-761
http://dx.doi.org/10.1172/JCI111757
[56] Kasprowicz DJ, Kohm AP, Berton MT, Chruscinski AJ, Sharpe A, Sanders VM(2000). Stimulation of the B cell receptor, CD86 (B7-2), and the beta 2-adrenergic receptor intrinsically modulates the level of IgG1 and IgE produced per B cell. J Immunol, 165:680-690
http://dx.doi.org/10.4049/jimmunol.165.2.680
[57] Kohm AP, Mozaffarian A, Sanders VM(2002). B cell receptor- and beta 2-adrenergic receptor-induced regulation of B7-2 (CD86) expression in B cells. J Immunol, 168:6314-6322
http://dx.doi.org/10.4049/jimmunol.168.12.6314
[58] Pongratz G, McAlees JW, Conrad DH, Erbe RS, Haas KM, Sanders VM(2006). The level of IgE produced by a B cell is regulated by norepinephrine in a p38 MAPK- and CD23-dependent manner. J Immunol, 177:2926-2938
http://dx.doi.org/10.4049/jimmunol.177.5.2926
[59] Wang D, Muller N, McPherson KG, Reichardt HM(2006). Glucocorticoids engage different signal transduction pathways to induce apoptosis in thymocytes and mature T cells. J Immunol, 176:1695-1702
http://dx.doi.org/10.4049/jimmunol.176.3.1695
[60] Chen X, Murakami T, Oppenheim JJ, Howard OM(2004). Differential response of murine CD4+CD25+ and CD4+CD25- T cells to dexamethasone-induced cell death. European journal of immunology, 34:859-869
http://dx.doi.org/10.1002/eji.200324506
[61] Ramirez F, Fowell DJ, Puklavec M, Simmonds S, Mason D(1996). Glucocorticoids promote a TH2 cytokine response by CD4+ T cells in vitro. J Immunol, 156:2406-2412
[62] Momcilovic M, Miljkovic Z, Popadic D, Markovic M, Savic E, Ramic Z(2008). Methylprednisolone inhibits interleukin-17 and interferon-gamma expression by both naive and primed T cells. BMC immunology, 9:47
http://dx.doi.org/10.1186/1471-2172-9-47
[63] Franchimont D, Galon J, Gadina M, Visconti R, Zhou Y, Aringer M(2000). Inhibition of Th1 immune response by glucocorticoids: dexamethasone selectively inhibits IL-12-induced Stat4 phosphorylation in T lymphocytes. J Immunol, 164:1768-1774
http://dx.doi.org/10.4049/jimmunol.164.4.1768
[64] Liberman AC, Druker J, Refojo D, Holsboer F, Arzt E(2009). Glucocorticoids inhibit GATA-3 phosphorylation and activity in T cells. FASEB journal: official publication of the Federation of American Societies for Experimental Biology, 23:1558-1571
http://dx.doi.org/10.1096/fj.08-121236
[65] Maneechotesuwan K, Yao X, Ito K, Jazrawi E, Usmani OS, Adcock IM(2009). Suppression of GATA-3 nuclear import and phosphorylation: a novel mechanism of corticosteroid action in allergic disease. PLoS medicine, 6:e1000076
http://dx.doi.org/10.1371/journal.pmed.1000076
[66] Biola A, Andreau K, David M, Sturm M, Haake M, Bertoglio J(2000). The glucocorticoid receptor and STAT6 physically and functionally interact in T-lymphocytes. FEBS letters, 487:229-233
http://dx.doi.org/10.1016/S0014-5793(00)02297-3
[67] Swanson MA, Lee WT, Sanders VM(2001). IFN-gamma production by Th1 cells generated from naive CD4+ T cells exposed to norepinephrine. J Immunol, 166:232-240
http://dx.doi.org/10.4049/jimmunol.166.1.232
[68] Bush KA, Krukowski K, Eddy JL, Janusek LW, Mathews HL(2012). Glucocorticoid receptor mediated suppression of natural killer cell activity: identification of associated deacetylase and corepressor molecules. Cellular immunology, 275:80-89
http://dx.doi.org/10.1016/j.cellimm.2012.02.014
[69] Gan X, Zhang L, Solomon GF, Bonavida B(2002). Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity. Brain, behavior, and immunity, 16:227-246
http://118.145.16.217/magsci/article/article?id=14764548
[70] Brait VH, Arumugam TV, Drummond GR, Sobey CG(2012). Importance of T lymphocytes in brain injury, immunodeficiency, and recovery after cerebral ischemia. J Cereb Blood Flow Metab, 32:598-611
http://dx.doi.org/10.1038/jcbfm.2012.6
[71] Morganti-Kossmann MC, Satgunaseelan L, Bye N, Kossmann T(2007). Modulation of immune response by head injury. Injury, 38:1392-1400
http://118.145.16.217/magsci/article/article?id=14247605
[72] Morganti-Kossmann MC, Rancan M, Stahel PF, Kossmann T(2002). Inflammatory response in acute traumatic brain injury: a double-edged sword. Curr Opin Crit Care, 8:101-105
http://dx.doi.org/10.1097/00075198-200204000-00002
[73] Kamel H, Iadecola C(2012). Brain-immune interactions and ischemic stroke: clinical implications. Arch Neurol, 69:576-581
http://dx.doi.org/10.1001/archneurol.2011.3590
[74] Whiting MJ, Doogue MP(2009). Advances in biochemical screening for phaeochromocytoma using biogenic amines. Clin Biochem Rev, 30:3-17
[75] Chamorro A, Amaro S, Vargas M, Obach V, Cervera A, Gomez-Choco M(2007). Catecholamines, infection, and death in acute ischemic stroke. J Neurol Sci, 252:29-35
http://dx.doi.org/10.1016/j.jns.2006.10.001
[76] Vogelgesang A, May VE, Grunwald U, Bakkeboe M, Langner S, Wallaschofski H(2010). Functional status of peripheral blood T-cells in ischemic stroke patients. PLoS One, 5:e8718
http://dx.doi.org/10.1371/journal.pone.0008718
[77] Prass K, Meisel C, Hoflich C, Braun J, Halle E, Wolf T(2003). Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med, 198:725-736
http://dx.doi.org/10.1084/jem.20021098
[78] Mracsko E, Liesz A, Karcher S, Zorn M, Bari F, Veltkamp R(2014). Differential effects of sympathetic nervous system and hypothalamic-pituitary-adrenal axis on systemic immune cells after severe experimental stroke. Brain, behavior, and immunity
[79] Wong CH, Jenne CN, Lee WY, Leger C, Kubes P(2011). Functional innervation of hepatic iNKT cells is immunosuppressive following stroke. Science, 334:101-105
http://dx.doi.org/10.1126/science.1210301
[80] Ajmo CTJr, Collier LA, Leonardo CC, Hall AA, Green SM, Womble TA(2009). Blockade of adrenoreceptors inhibits the splenic response to stroke. Exp Neurol, 218:47-55
http://dx.doi.org/10.1016/j.expneurol.2009.03.044
[81] Fassbender K, Schmidt R, Mossner R, Daffertshofer M, Hennerici M(1994). Pattern of activation of the hypothalamic-pituitary-adrenal axis in acute stroke. Relation to acute confusional state, extent of brain damage, and clinical outcome. Stroke, 25:1105-1108
http://dx.doi.org/10.1161/01.STR.25.6.1105
[82] Franceschini R, Gandolfo C, Cataldi A, Del Sette M, Cianciosi P, Finocchi C(1994). Twenty-four-hour beta-endorphin secretory pattern in stroke patients. Stroke, 25:2142-2145
http://dx.doi.org/10.1161/01.STR.25.11.2142
[83] Olsson T(1990). Urinary free cortisol excretion shortly after ischaemic stroke. J Intern Med, 228:177-181
http://dx.doi.org/10.1111/j.1365-2796.1990.tb00213.x
[84] Emsley H(2003). An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis. Journal of neuroimmunology, 139:93-101
http://dx.doi.org/10.1016/S0165-5728(03)00134-6
[85] Marklund N, Peltonen M, Nilsson TK, Olsson T(2004). Low and high circulating cortisol levels predict mortality and cognitive dysfunction early after stroke. J Intern Med, 256:15-21
http://dx.doi.org/10.1111/j.1365-2796.2004.01334.x
[86] Neidert S, Katan M, Schuetz P, Fluri F, Ernst A, Bingisser R(2011). Anterior pituitary axis hormones and outcome in acute ischaemic stroke. J Intern Med, 269:420-432
http://dx.doi.org/10.1111/j.1365-2796.2010.02327.x
[87] Christensen H, Boysen G, Johannesen HH(2004). Serum-cortisol reflects severity and mortality in acute stroke. J Neurol Sci, 217:175-180
http://dx.doi.org/10.1016/j.jns.2003.09.013
[88] O’Neill PA, Davies I, Fullerton KJ, Bennett D(1991). Stress hormone and blood glucose response following acute stroke in the elderly. Stroke, 22:842-847
http://dx.doi.org/10.1161/01.STR.22.7.842
[89] Murros K, Fogelholm R, Kettunen S, Vuorela AL(1993). Serum cortisol and outcome of ischemic brain infarction. J Neurol Sci, 116:12-17
http://dx.doi.org/10.1016/0022-510X(93)90083-B
[90] Anne M, Juha K, Timo M, Mikko T, Olli V, Kyosti S(2007). Neurohormonal activation in ischemic stroke: effects of acute phase disturbances on long-term mortality. Curr Neurovasc Res, 4:170-175
http://dx.doi.org/10.2174/156720207781387169
[91] Szczudlik A, Dziedzic T, Bartus S, Slowik A, Kieltyka A(2004). Serum interleukin-6 predicts cortisol release in acute stroke patients. J Endocrinol Invest, 27:37-41
http://dx.doi.org/10.1007/BF03350908
[92] Weidenfeld J, Leker RR, Gai N, Teichner A, Bener D, Ovadia H(2011). The function of the adrenocortical axis in permanent middle cerebral artery occlusion: effect of glucocorticoids on the neurological outcome. Brain Res, 1407:90-96
http://dx.doi.org/10.1016/j.brainres.2011.06.035
[93] Torres KC, Antonelli LR, Souza AL, Teixeira MM, Dutra WO, Gollob KJ(2005). Norepinephrine, dopamine and dexamethasone modulate discrete leukocyte subpopulations and cytokine profiles from human PBMC. Journal of neuroimmunology, 166:144-157
http://dx.doi.org/10.1016/j.jneuroim.2005.06.006
[94] Woiciechowsky C, Asadullah K, Nestler D, Eberhardt B, Platzer C, Schoning B(1998). Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat Med, 4:808-813
http://dx.doi.org/10.1038/nm0798-808
[95] Johansson PI, Stensballe J, Rasmussen LS, Ostrowski SR(2012). High circulating adrenaline levels at admission predict increased mortality after trauma. The journal of trauma and acute care surgery, 72:428-436
[96] Ostrowski SR, Pedersen SH, Jensen JS, Mogelvang R, Johansson PI(2013). Acute myocardial infarction is associated with endothelial glycocalyx and cell damage and a parallel increase in circulating catecholamines. Crit Care, 17:R32
http://dx.doi.org/10.1186/cc12532
[97] Christensen NJ, Videbaek J(1974). Plasma catecholamines and carbohydrate metabolism in patients with acute myocardial infarction. The Journal of clinical investigation, 54:278-286
http://dx.doi.org/10.1172/JCI107763
[98] Haeusler KG, Schmidt WU, Foehring F, Meisel C, Guenther C, Brunecker P(2012). Immune responses after acute ischemic stroke or myocardial infarction. Int J Cardiol, 155:372-377
http://dx.doi.org/10.1016/j.ijcard.2010.10.053
[99] Goldstein RS, Gallowitsch-Puerta M, Yang L, Rosas-Ballina M, Huston JM, Czura CJ(2006). Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia. Shock, 25:571-574
http://dx.doi.org/10.1097/01.shk.0000209540.99176.72
[100] Haeusler KG, Schmidt WU, Fohring F, Meisel C, Helms T, Jungehulsing GJ(2008). Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans. Cerebrovasc Dis, 25:50-58
[101] Kossmann T, Hans VH, Imhof HG, Stocker R, Grob P, Trentz O(1995). Intrathecal and serum interleukin-6 and the acute-phase response in patients with severe traumatic brain injuries. Shock, 4:311-317
http://dx.doi.org/10.1097/00024382-199511000-00001
[102] Ruparelia N, Digby JE, Jefferson A, Medway DJ, Neubauer S, Lygate CA(2013). Myocardial infarction causes inflammation and leukocyte recruitment at remote sites in the myocardium and in the renal glomerulus. Inflammation research: official journal of the European Histamine Research Society [et al], 62:515-525
http://dx.doi.org/10.1007/s00011-013-0605-4
[103] Fukui D, Yasukawa H, Sugi Y, Oba T, Nagata T, Kyogoku S(2012). Transient reduction and activation of circulating dendritic cells in patients with acute myocardial infarction. Int J Cardiol, 160:216-219
http://dx.doi.org/10.1016/j.ijcard.2012.06.070
[104] Urra X, Cervera A, Obach V, Climent N, Planas AM, Chamorro A(2009). Monocytes are major players in the prognosis and risk of infection after acute stroke. Stroke, 40:1262-1268
http://dx.doi.org/10.1161/STROKEAHA.108.532085
[105] Riegger T, Conrad S, Liu K, Schluesener HJ, Adibzahdeh M, Schwab JM(2007). Spinal cord injury-induced immune depression syndrome (SCI-IDS)The European journal of neuroscience, 25:1743-1747
http://dx.doi.org/10.1111/j.1460-9568.2007.05447.x
[106] Menges P, Kessler W, Kloecker C, Feuerherd M, Gaubert S, Diedrich S(2012). Surgical trauma and postoperative immune dysfunction. Eur Surg Res, 48:180-186
http://dx.doi.org/10.1159/000338196
[107] Riegger T, Conrad S, Schluesener HJ, Kaps HP, Badke A, Baron C(2009). Immune depression syndrome following human spinal cord injury (SCI): a pilot study. Neuroscience, 158:1194-1199
http://dx.doi.org/10.1016/j.neuroscience.2008.08.021
[108] Kirchhoff C, Biberthaler P, Mutschler WE, Faist E, Jochum M, Zedler S(2009). Early down-regulation of the pro-inflammatory potential of monocytes is correlated to organ dysfunction in patients after severe multiple injury: a cohort study. Crit Care, 13:R88
http://dx.doi.org/10.1186/cc7914
[109] Klehmet J, Harms H, Richter M, Prass K, Volk HD, Dirnagl U(2009). Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial. Neuroscience, 158:1184-1193
http://dx.doi.org/10.1016/j.neuroscience.2008.07.044
[110] Li M, Li F, Luo C, Shan Y, Zhang L, Qian Z(2011). Immediate splenectomy decreases mortality and improves cognitive function of rats after severe traumatic brain injury. J Trauma, 71:141-147
http://dx.doi.org/10.1097/TA.0b013e3181f30fc9
[111] Silveira FP, Nicoluzzi JE, Saucedo Junior NS, Silveira F, Nicollelli GM, Maranhao BS(2012). Evaluation of serum levels of interleukin-6 and interleukin-10 in patients undergoing laparoscopic versus conventional cholecystectomy. Rev Col Bras Cir, 39:33-40
http://dx.doi.org/10.1590/S0100-69912012000100008
[112] Chu W, Li M, Li F, Hu R, Chen Z, Lin J(2013). Immediate splenectomy down-regulates the MAPK-NF-kappaB signaling pathway in rat brain after severe traumatic brain injury. The journal of trauma and acute care surgery, 74:1446-1453
http://dx.doi.org/10.1097/TA.0b013e31829246ad
[113] Dziedzic T, Slowik A, Szczudlik A(2004). Nosocomial infections and immunity: lesson from brain-injured patients. Crit Care, 8:266-270
http://dx.doi.org/10.1186/cc2828
[114] Wang KY, Yu GF, Zhang ZY, Huang Q, Dong XQ(2012). Plasma high-mobility group box 1 levels and prediction of outcome in patients with traumatic brain injury. Clinica chimica acta; international journal of clinical chemistry, 413:1737-1741
http://dx.doi.org/10.1016/j.cca.2012.07.002
[115] Peltz ED, Moore EE, Eckels PC, Damle SS, Tsuruta Y, Johnson JL(2009). HMGB1 is markedly elevated within 6 hours of mechanical trauma in humans. Shock, 32:17-22
http://dx.doi.org/10.1097/SHK.0b013e3181997173
[116] Urra X, Cervera A, Villamor N, Planas AM, Chamorro A(2009). Harms and benefits of lymphocyte subpopulations in patients with acute stroke. Neuroscience, 158:1174-1183
http://dx.doi.org/10.1016/j.neuroscience.2008.06.014
[117] Czlonkowska A, Korlak J(1979). [Humoral immune response in patients with stroke]. Pol Tyg Lek, 34:485-487
[118] Cheng X, Liao YH, Ge H, Li B, Zhang J, Yuan J(2005). TH1/TH2 functional imbalance after acute myocardial infarction: coronary arterial inflammation or myocardial inflammation. Journal of clinical immunology, 25:246-253
http://118.145.16.217/magsci/article/article?id=15665859
[119] Griffin GD(2011). The injured brain: TBI, mTBI, the immune system, and infection: connecting the dots. Mil Med, 176:364-368
http://dx.doi.org/10.7205/MILMED-D-10-00021
[120] Wolach B, Sazbon L, Gavrieli R, Broda A, Schlesinger M(2001). Early immunological defects in comatose patients after acute brain injury. J Neurosurg, 94:706-711
http://dx.doi.org/10.3171/jns.2001.94.5.0706
[121] Schulze J, Zierath D, Tanzi P, Cain K, Shibata D, Dressel A(2013). Severe stroke induces long-lasting alterations of high-mobility group box 1. Stroke, 44:246-248
http://dx.doi.org/10.1161/STROKEAHA.112.676072
[122] Kawabata H, Setoguchi T, Yone K, Souda M, Yoshida H, Kawahara K(2010). High mobility group box 1 is upregulated after spinal cord injury and is associated with neuronal cell apoptosis. Spine (Phila Pa 1976)35:1109-1115
[123] Angele MK, Chaudry IH(2005). Surgical trauma and immunosuppression: pathophysiology and potential immunomodulatory approaches. Langenbecks Arch Surg, 390:333-341
http://118.145.16.217/magsci/article/article?id=15758816
[124] Castillo L, Velasco N, Wainstein C, Bugedo G, Hernandez G, Klaassen J(1999). [Transcranial cytokine gradient and intestinal permeability in acute severe brain injury]. Rev Med Chil, 127:639-646
[125] Hernandez G, Hasbun P, Velasco N, Wainstein C, Bugedo G, Bruhn A(2007). Splanchnic ischemia and gut permeability after acute brain injury secondary to intracranial hemorrhage. Neurocrit Care, 7:40-44
http://118.145.16.217/magsci/article/article?id=16808344
[126] Jiang XH, Li N, Li JS(2003). Intestinal permeability in patients after surgical trauma and effect of enteral nutrition versus parenteral nutrition. World J Gastroenterol, 9:1878-1880
http://118.145.16.217/magsci/article/article?id=10040209
[127] O’Boyle CJ, MacFie J, Mitchell CJ, Johnstone D, Sagar PM, Sedman PC(1998). Microbiology of bacterial translocation in humans. Gut, 42:29-35
http://dx.doi.org/10.1136/gut.42.1.29
[128] MacFie J(1997). Bacterial translocation in surgical patients. Ann R Coll Surg Engl, 79:183-189
[129] Bansal V, Costantini T, Ryu SY, Peterson C, Loomis W, Putnam J(2010). Stimulating the central nervous system to prevent intestinal dysfunction after traumatic brain injury. J Trauma, 68:1059-1064
http://dx.doi.org/10.1097/TA.0b013e3181d87373
[130] Heffernan DS, Inaba K, Arbabi S, Cotton BA(2010). Sympathetic hyperactivity after traumatic brain injury and the role of beta-blocker therapy. J Trauma, 69:1602-1609
http://dx.doi.org/10.1097/TA.0b013e3181f2d3e8
[131] Salehpoor F, Bazzazi AM, Estakhri R, Zaheri M, Asghari B(2010). Correlation between catecholamine levels and outcome in patients with severe head trauma. Pak J Biol Sci, 13:738-742
http://dx.doi.org/10.3923/pjbs.2010.738.742
[132] Woolf PD, Hamill RW, Lee LA, Cox C, McDonald JV(1987). The predictive value of catecholamines in assessing outcome in traumatic brain injury. J Neurosurg, 66:875-882
http://dx.doi.org/10.3171/jns.1987.66.6.0875
[133] Ruhnau J, Schulze K, Gaida B, Langner S, Kessler C, Broker B(2014). Stroke alters respiratory burst in neutrophils and monocytes. Stroke, 45:794-800
http://dx.doi.org/10.1161/STROKEAHA.113.003342
[1] Alexandra Moura,José Madureira,Pablo Alija,João Carlos Fernandes,José Gerardo Oliveira,Martin Lopez,Madalena Filgueiras,Leonilde Amado,Maria Sameiro-Faria,Vasco Miranda,Alice Santos-Silva,Elísio Costa. Effect of Aging in the Perception of Health-Related Quality of Life in End-Stage Renal Disease Patients under Online-Hemodiafiltration[J]. Aging and Disease, 2015, 6(1): 17-26.
[2] Amanda Piano,Vladimir I. Titorenko. The Intricate Interplay between Mechanisms Underlying Aging and Cancer[J]. Aging and Disease, 2015, 6(1): 56-75.
[3] Kunlin Jin,James W. Simpkins,Xunming Ji,Miriam Leis,Ilia Stambler. The Critical Need to Promote Research of Aging and Aging-related Diseases to Improve Health and Longevity of the Elderly Population[J]. Aging and Disease, 2015, 6(1): 1-5.
[4] Shinichi Iwasaki,Tatsuya Yamasoba. Dizziness and Imbalance in the Elderly: Age-related Decline in the Vestibular System[J]. Aging and Disease, 2015, 6(1): 38-47.
[5] Baugé Catherine,Girard Nicolas,Lhuissier Eva,Bazille Celine,Boumediene Karim. Regulation and Role of TGFβ Signaling Pathway in Aging and Osteoarthritis Joints[J]. Aging and Disease, 2014, 5(6): 394-405.
[6] Bolanle M. Famakin. The Immune Response to Acute Focal Cerebral Ischemia and Associated Post-stroke Immunodepression: A Focused Review[J]. Aging and Disease, 2014, 5(5): 307-326.
[7] Ashley B. Petrone,James W. Simpkins,Taura L. Barr. 17β-Estradiol and Inflammation: Implications for Ischemic Stroke[J]. Aging and Disease, 2014, 5(5): 340-345.
[8] David Blokh,Ilia Stambler. Estimation of Heterogeneity in Diagnostic Parameters of Age-related Diseases[J]. Aging and Disease, 2014, 5(4): 218-225.
[9] Olaoluwa O Okusaga. Accelerated Aging in Schizophrenia Patients: The Potential Role of Oxidative Stress[J]. Aging and Disease, 2014, 5(4): 256-262.
[10] Shaohua Xu,Ying Cai,Yuehua Wei. mTOR Signaling from Cellular Senescence to Organismal Aging[J]. Aging and Disease, 2014, 5(4): 263-273.
[11] Alejandro Lucas-Sánchez,Pedro Francisco Almaida-Pagán,Pilar Mendiola,Jorge de Costa. Nothobranchius as a model for aging studies. A review[J]. Aging and Disease, 2014, 5(4): 281-291.
[12] Chandan Prasad,Victorine Imrhan,Francesco Marotta,Shanil Juma,Parakat Vijayagopal. Lifestyle and Advanced Glycation End Products (AGEs) Burden: Its Relevance to Healthy Aging[J]. Aging and Disease, 2014, 5(3): 212-217.
[13] Ninu Poulose,Raghavan Raju. Aging and Injury: Alterations in Cellular Energetics and Organ Function[J]. Aging and Disease, 2014, 5(2): 101-108.
[14] Peter M Nilsson. Hemodynamic Aging as the Consequence of Structural Changes Associated with Early Vascular Aging (EVA)[J]. Aging and Disease, 2014, 5(2): 109-113.
[15] Ryan Oakley,Binu Tharakan. Vascular Hyperpermeability and Aging[J]. Aging and Disease, 2014, 5(2): 114-125.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
Copyright © 2014 Aging and Disease, All Rights Reserved.
Address: Aging and Disease Editorial Office 3400 Camp Bowie Boulevard Fort Worth, TX76106 USA
Fax: (817) 735-0408 E-mail: editorial@aginganddisease.org
Powered by Beijing Magtech Co. Ltd